Nanoform Finland Oyj Sustainability Reports

Nanoform Finland Oyj provides nanotechnology and drug particle engineering services to the pharmaceutical and biotechnology industries. The company specializes in improving the bioavailability and efficacy of drug molecules through its proprietary particle size reduction technologies.

Sector: Manufacturing

Country: Finland

Exchange: Nasdaq Helsinki

LEI: 743700JJO2NU8LBS1592

FIGI: BBG00TSCF5V7

17 reports from 2019 to 2025

• Nanoform Finland Oyj 2025 Corporate Governance Statement
• Nanoform Finland Oyj 2025 Board of Directors' Report and Financial Statements for the Financial Year
• Nanoform Finland Oyj 2024 Corporate Governance Statement
• Nanoform Finland Oyj 2024 Report of the Board of Directors and Financial Statements
• Nanoform Finland Oyj 2024 Board's Report and Financial Statements